Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Prostatic Neoplasms 1Neuralgia 1

Interventions

Pregabalin 5Lidocaine 4Bupivacaine 3ziconotide 2Transcranial Magnetic Stimulation 2Gabapentin 2Capsaicin 2Amitriptyline 2onabotulinum toxin A 1Yoga 1Vitamin B 6 1Vitamin B 12 1Vinorelbine 1Vincristine 1Transcutaneous Electric Nerve Stimulation 1Thalidomide 1Telmisartan 1Surveys and Questionnaires 1Spinal Cord Stimulation 1Sodium Chloride 1Saline Solution 1Radiofrequency Ablation 1Paclitaxel 1Oxycodone 1Oxaliplatin 1Manipulation, Osteopathic 1Low-Level Light Therapy 1Lidoderm 1Ketamine 1KRN 5500 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neuralgia × Telmisartan × Clear all
NCT05322889 2024-08-28

PrevTel

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP

Phase 2 Completed
35 enrolled
BreastGynecologic

Breast Neoplasms, Neuralgia, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡